How are you taking part in this consultation?

You will not be able to change how you comment later.

You must be signed in to answer questions

  • Question on Consultation

    Has all of the relevant evidence been taken into account?
  • Question on Consultation

    Are the summaries of clinical and cost effectiveness reasonable interpretations of the evidence?
  • Question on Consultation

    Are the recommendations sound and a suitable basis for guidance to the NHS?
  • Question on Consultation

    Are there any equality issues that need special consideration and are not covered in the medical technology consultation document?
The content on this page is not current guidance and is only for the purposes of the consultation process.

6 Implementation considerations

The following considerations around implementing the evidence generation process have been identified through working with system partners:

Evidence generation

  • The companies should collect and analyse outcome data carefully to ensure that important subgroups are included in the studies, such as people:

    • people under 50

    • people with obesity where the field of view for a radiograph may include more surrounding tissue

    • people with cancer and

    • people with osteogenesis imperfecta.

Equalities

  • During implementation of AI technologies, having limited access to fracture liaison services, fragility fractures and osteoporosis treatments in the NHS may drive health inequalities. This could worsen regional inequalities, particularly for people living in deprived areas.

System and implementation considerations

  • It is unknown how these AI technologies might impact the skills of the healthcare professional to detect vertebral fragility fractures. Care should be taken to ensure that healthcare professionals are not deskilled by over reliance on AI technologies.

  • The companies should ideally provide or support training for healthcare professionals in using the technologies.

ISBN: [to be added at publication]